Direct Oral Anticoagulant Assay Detection & Classification Study for the TEG 6S System
Status: Completed
Location: See all (4) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
Observational trial to evaluate the effectiveness of the TEG6s DOAC cartridge to detect and classify the presence of DOAC drugs in a subject.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• ≥ 18 years old
• DOAC administered for a minimum of 7 days
Locations
United States
Indiana
Memorial Hospital South Bend
South Bend
Minnesota
Essentia Institute of Rural Health
Duluth
South Carolina
Spartanburg Regional Healthcare System
Spartanburg
Virginia
Inova Health Care Services
Falls Church
Time Frame
Start Date: 2016-08
Completion Date: 2017-09
Participants
Target number of participants: 385
Treatments
Reference Range
Healthy Subjects
DOAC Pivotal
DOAC Eligible Subjects
Authors
Sponsors
Leads: Haemonetics Corporation